A potential function of RLIP76 in the ovarian corpus luteum

Ral interacting protein of 76 kDa is a modular protein which is capable of interacting with diverse functional proteins [14]. The encoding gene of RLIP76 is located on human chromosome 18p11 [7]. The primary structure of RLIP76 protein constructed by 655 amino acids can be divided into four main regions which are N-terminal region (aa 171–185), Rho-Gap region (aa 210–357), Ral binding region (aa 402–498), and C-terminal region (aa 500–647) [7, 15]. RLIP76 is a vital protein involved in various regulation of cellular and physiological functions through its domain structure as well as adapter sites for multiple signaling proteins [16].

In Ras signaling pathway, Ral-GTPase plays an essential role in a distinct downstream pathway of Ras protein activator [17]. RLIP76, an effector of Ral proteins, appears to participate in endocytosis regulation by binding with several protein partners. In response to epidermal growth factor (EGF) stimulation on a cell surface, protein partners such as RalBP1-associated Eps homology protein 1 (Reps1) and partner of RalBP1 (POB1) bind to C-terminal region of RLIP76 that positively influence on endocytosis and/or cytoskeleton [17, 18]. Both Reps1 and POB1 contain an Eps15 homology domain detected in the EGF receptor substrate [17, 19]. Moreover, an endocytotic machinery protein such as AP2 protein can interact with RLIP76 through its medium chain (μ2) that binds directly on the N-terminal region of RLIP76 [20]. Those protein partners including Resp1, POB1, and AP2 are important for RLIP76 to behave appropriately in endocytosis regulation [20].

In clathrin-dependent endocytosis mechanism, RLIP76 involved in endocytotic machinery as a motor protein appears to be integral with its transport function [10]. RLIP76 has identical function and biochemical properties of dinitrophenyl S-glutathione (DNP-SG) ATPase protein that can catalyze transport of glutathione conjugates and xenobiotic across the biological membrane [21]. RLIP76 is a non-ATP binding cassette (ABC) transporter, but it has two ATP binding sites that exhibit transporting capability of diverse substrates including weakly cationic and anionic compounds [22, 23]. The ATP binding sites of RLIP76 were identified to be ⁶⁹GKKKGK⁷⁴ and ⁴¹⁸GGIKDLSK⁴²⁵ respectively located in the N-terminal and C-terminal region of RLIP76 [22]. In addition, the transport function of RLIP76 plays an important role in the cell stress response mechanism [24]. Furthermore, under the stress condition, RLIP76 mediates the activation of heat shock factor 1 (HSF1) in response to the activation of Ral signal transduction pathway [25].

In Ral signaling pathway, RLIP76 plays a vital role in mediating numerous cellular processes of small Ras-like GTPase protein associated with its Ral binding region. RLIP76 markedly promotes mitochondrial fission during mitosis through its association with RalA [26]. RLIP76 also acts to regulate actin remodeling due to the activation of RalB induced by FGF (fibroblast growth factor) signal transduction [27]. Moreover, RLIP76 participates in bridging the Ral GTPase to Rho pathways that modulate the activity of CDC42/Rac/Rho Pathway [7]. To that, RLIP76 is critical for adhesion-mediated Rac activation via its Rho-Gap region that regulates cell migration and spreading [28]. Collectively, RLIP76 is involved in various cellular and physiological function such as endocytosis, metabolite transport, stress responses, mitosis, actin remodeling, cell migration and spreading (Fig. 1). Thus, the variety of domains and motifs that belongs to RLIP76 provides heterogeneous ability in cellular function as a multifunctional protein [29].

The presence of RLIP76 appears to be indispensable for cancer cells indicated by its overexpression in various malignant cell lines. Investigations of RLIP76 protein expression level in a number of cells involving detection by Western blot analyses, purification by DNP-SG affinity chromatography, and quantification by enzyme-linked immunosorbent assay (ELISA) were conducted in certain previous studies. The expression of RLIP76 in several malignant cell lines including Caki-2 (human kidney), DG-1 (human melanoma), H358 (human lung, NSCLC), H1618 (human lung, SCLC), OVCAR-3 (human ovary), PC-3 (human prostate), and SW-480 (human colon) were discovered relatively greater amount compared to normal cells [30, 31]. The higher expression of RLIP76 protein in cancer cell lines occurred in line with its greater activity [31]. RLIP76 upregulation in malignant cells is associated with its function to counter apoptosis mechanism that heavily contributes to the cancer cell viability.

In the hierarchy of stress defense mechanisms of cancer cell survival, RLIP76 is an anti-apoptotic protein that occupies a prominent signaling pathway as a glutathione-conjugates (GS-E) and xenobiotic transporter [32]. RLIP76 actively participates in efflux pumping of 4-Hydroxy-t-2,3-nonenal (4HNE) and chemotherapeutic drugs resulted in apoptosis resistance of lung cancer cells [33, 34]. Furthermore, the cytotoxicity of chemotherapeutic drugs mediated apoptosis such as anthracycline (DOX), and vinca-alkaloids (vinblastine, vincristine, and vinorelbine) were relatively low in kidney cancer cells due to RLIP76 overexpression and its transport function [35]. RLIP76 is an ATP-dependent transporter by which its transport activity is provoked as an outcome of phosphorylation by protein kinase C (PKC)-α [36, 37]. The ATPase activity and transport function of RLIP76 remarkably contributes to anti-apoptosis and multidrug resistance (MDR) mechanism in cancer cell [21, 35].

In oxidation, radiation, and heat exposure, RLIP76 also emerges to be vital in the stress response mechanism generating cells resistance to apoptosis. Under mild oxidative stress state, RLIP76 was found to be upregulated on the surface membrane of EAhy926 endothelial cells that contributes to physiologic cellular defenses [38]. RLIP76 also plays a role as a radioprotective agent in which significantly improves the survival duration of mice treated with RLIP76 liposomes exposed by 500-cGy X-irradiation [39]. Moreover, RLIP76 was identified to interact with HSF1 in heterocomplexes [25]. In response to mild transient heat shock exposure, the human cancer cells including K562 (human leukemia), H-226 (human, NSCLC) and H-69 (human, SCLC) incubated with hGST5.8 and RLIP76 produce cells resistance to apoptosis [24].

The blocking or depletion of RLIP76 significantly caused apoptosis in cancer cell lines by which interfere its anti-apoptotic physiological function [40, 41]. RLIP76 plays an important role in apoptosis inhibition by controlling intracellular concentration of pro-apoptotic endogenous lipid peroxidation byproducts through its transport function [24, 42]. In addition, RLIP76 essentially participates in mediating the activation of PI3K/Akt signaling pathway that induces further activation of mTOR which suppresses the expression of the pro-apoptotic constituents [43]. Furthermore, RLIP76 absence appears to be crucial that leads to apoptosis via the activation of the c-Jun kinase (JNK)/stress activated protein kinase and caspase 3 [24]. Thus, RLIP76 is key stress defensive and anti-apoptotic protein that is vitally involved in apoptosis regulation [23].

Angiogenesis is the process of new blood vessel formation originated from the preexisting mature vessel [44]. Multiple regulators, mediators, and signal transduction pathways are involved in the angiogenesis complex process [45, 46]. The pro-angiogenic factors are essential to angiogenesis initiating the proliferation and migration of endothelial cells throughout the neovascularization process [47, 48]. Angiogenesis provides blood supply from the host vascular system that essentially nourishes tumor progression [6].

For a tumor to grow and become malignant, owning blood supply through angiogenesis is heavily required to develop the size beyond 1 mm in diameter [49]. Our previous study involving RLIP76−/− mice implanted with melanoma or carcinoma cell conclusively demonstrated that RLIP76 is necessary for angiogenesis and neovascularization of primary solid tumors [50]. In addition, the blockade of RLIP76 reported in several previous researches led to complete regression in the mice xenograft model of the human lung [32], colon [32], prostate [51], and pancreatic cancer cells [43]. Moreover, angiogenesis is not only fundamentally required for solid tumor development but also metastasis [52].

In tumor growth, the expression of RLIP76 is related to cell migration and is requisite for human cancer cell metastasis [53]. RLIP76 actively participates in cell spreading and migration by regulating Rac1 and Arf6 signaling pathway [54]. In cell mechanism, RLIP76 mediates R-Ras to adhesion-induced Rac activation via a GTPase cascade [28]. The Rho-Gap domain of RLIP76 provides directly binding to R-Ras in a GTP-dependent manner resulted in adhesion-mediated the activation of Arf6 GTPase [28]. In the activation of Arf6, RLIP76 regulates Arf6 via PI3-Kinase-dependent pathway by which RLIP76 contribute to link R-Ras-dependent trisphosphate (PIP3) in the recruitment of a guanine nucleotide exchange factor for Arf6 (ARNO) [54]. The interaction of ARNO with serine residues 29 and 30 of the RLIP76 N-terminus renders the enhancement of Arf6 activation [54]. Subsequently, the activated Arf6 GTPase leads to the promotion of Rac1 GTPase activation [28]. Thus, RLIP76 plays a vital role as a critical link in a small GTPases downstream effect in Rac1 and Arf6 signaling pathway which is essential for tumor angiogenesis.

The corpus luteum is a heterogenous gland consisted of the large and small luteal cell, endothelial cells, fibroblasts, smooth muscle cells, and immune cells [55]. In the cyclical remodeling of corpus luteum, the regular period of growth, function, and luteolysis occur during the corpus luteum life span [2]. The corpus luteum formation takes place subsequent to ovulation by which constituted of residual follicular wall cells (granulosa and theca cells) [4]. Series of morphological and biochemical changes in cells of theca interna and granulosa of the preovulatory follicles characterize the initiation process of corpus luteum establishment [2]. Certain processes including luteinization of follicular cells, endothelial cell invasion, and tissue remodeling are essential in the establishment of corpus luteum [56].

In the normal functioning of the female reproductive system, angiogenesis plays critical role in the follicular development and establishment of the corpus luteum [13]. The blockade of angiogenesis bears a significant effect in the attenuation of folliculogenesis, the nuisance of ovulation, and the disruption of the development and physiological function of the corpus luteum [57]. Profound angiogenesis takes place in the corpus luteum which is the formation site of a dense capillary network providing the hormone-producing cells for acquiring the oxygen, nutrients, and hormone precursors required for synthesizing and releasing a large number of progesterone hormones [58]. The angiogenesis in corpus luteum characterized by the intense blood vessel formation is frequently compared with angiogenesis in rapidly growing and malignant tumor [4].

An initial presumption that RLIP76 may participate in angiogenesis within the ovary emerge from our previous study result in primary solid tumor neovascularization. RLIP76 plays a critical role in solid tumor progression through angiogenesis derived from the host vascular cells [50]. In the inspection of tumor blood vessel formation in blunted RLIP76 −/− mice, the dimension and density of blood vessel appear to be fewer than wild-type mice. The appearance of the central vessel in the xenografted tumor of wild-type mice was thicker and longer with many branching vessels compared to blunted RLIP76 −/− mice based on 3-dimensional structure produced by the X-ray μCt scanning. The smaller total vascular volume and diameter of tumor in the blunted RLIP76 −/− mice indicated that blockade of RLIP76 impaired efficient neovascularization in implanted solid tumor. RLIP76 plays role independently to the growth of tumor cells and angiogenesis from the host vasculature in solid tumors. In Matrigel in vivo, RLIP76 is necessitated for angiogenesis by which the blood and blood vessel were completely devoid in the Matrigel plugs implanted in blunted RLIP76 −/− mice with or without vascular endothelial growth factor (VEGF). Furthermore, Investigation of cellular mechanism in microvasculature endothelial cells isolated from wild-type and RLIP76 −/− mice in vitro discovered that RLIP76 is required for efficient endothelial cell migration, proliferation, and cord formation fundamentally involved in the angiogenesis process [50].

A strong promoter of angiogenesis, VEGF, plays a critical role for corpus luteum formation and its physiological function in mammalian ovaries [59]. Inhibition of VEGF in a rat model treated with truncated soluble Flt-1 receptors resulted in massive suppression of corpus luteum angiogenesis [60]. In corpus luteum angiogenesis observed in mares, expression of VEGF mRNA and protein were found to be upregulated in the early and mid-luteal phases [61]. Similar result related to the upregulation of VEGF expression during corpus luteum angiogenesis also reported in several previous study in porcine, ovine, bovine, mice and human [62‐66].

Our previous study in revealing the mechanism of RLIP76 regulating endothelial cells angiogenic response convinces an insight that RLIP76 may involve in angiogenesis within the ovary. RLIP76 demonstrates a vital role as an angiogenic factor that is required for expression and secretion of VEGF in tumor cells [52]. Transient transfection of RLIP76 small hairpin RNA (shRNA) plasmid into B16F10 mouse melanoma and Lewis lung carcinoma cells resulted in decreasing of VEGF expression level. Melanoma and carcinoma cells transfected with RLIP76 shRNA exhibit incapability to stimulate proliferation and migration of BAEC (Bovine aortic endothelial cells) in conditioned medium in vitro. RLIP76 mainly participates in transactivation of endothelial cells by the tumor secretome through regulating the expression and secretion of angiogenic genes including VEGF in tumor cells [52].

In pro-angiogenic protein regulation, the hypoxia-induced mechanism is significantly involved in promoting the upregulation of VEGF expression [67]. The hypoxia-inducible factor-1 α (HIF-1α) plays a vital role in mediating the expression of VEGF in luteal cell during mammalian corpus luteum establishment through the hypoxia-induced transcriptional mechanism [59]. In a study of ovarian angiogenesis, the mRNA expression of HIF-1 was found to be upregulated in the early luteal phase during corpus luteum formation [64]. Evidently, the emergence of RLIP76 is essential for efficient HIF-1 activation in which depletion of RLIP76 led to a significance blockade of HIF-1 transcriptional activity in both melanoma and carcinoma cell under normoxic conditions [52].

Multiple steps involved in activation of HIF-1 transcription in which posttranslational modifications such as stabilization of HIF-1α subunit, phosphorylation, and nuclear translocation appear to contribute in proper transactivation activity of the HIF-1 regulation [68]. In HIF-1 signaling pathway, PI3K /Akt signal transduction plays a vital role in HIF-1 activation by which PI3-kinase activities are required for induction of HIF-1α protein expression [69]. The previous study of human chorionic gonadotrophin (hCG) role in corpus luteum angiogenesis reported that PI3K/Akt signaling pathway significantly contributes to the induction of VEGF and HIF-1 expression in the luteal cell under both hypoxic and normoxic condition [70]. In a study of pancreatic cancer, RLIP76 plays an important role in PI3K phosphorylation which is essential as an upstream signal signaling node in transducing mitogenic signals related to cell membrane receptors such as growth factors and integrins [43]. Those growth factors and integrins are vitally involved in the angiogenesis signaling pathway [48].

In summary, RLIP76 is essential in tumor angiogenesis through the regulation of pro-angiogenic factors such as VEGF and HIF-1 (Fig. 2). RLIP76 is vital protein for tumor progression and is expressed in various tissues including the ovary. Ovarian corpus luteum requires blood supply in order to develop and to function properly. The cellular mechanisms of the normal and tumor ovary were found to be homogeneous throughout the process of neovascularization [45]. Furthermore, the expression pro-angiogenic factors such as VEGF and HIF-1 was discovered to be upregulated during the corpus luteum angiogenesis. Taken together, the RLIP76 may be required for corpus luteum formation and its physiological function (Fig. 3).